# Study of the Key Techniques of Prevention and Treatment of Osteoporotic Refracture

> **NCT05866029** · NA · RECRUITING · sponsor: **Peking Union Medical College Hospital** · enrollment: 2478 (estimated)

## Conditions studied

- Osteoporotic Fractures

## Interventions

- **DRUG:** Denosumab
- **DRUG:** Teriparatide

## Key facts

- **NCT ID:** NCT05866029
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-05-26
- **Primary completion:** 2026-09-30
- **Final completion:** 2026-09-30
- **Target enrollment:** 2478 (ESTIMATED)
- **Last updated:** 2026-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05866029

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05866029, "Study of the Key Techniques of Prevention and Treatment of Osteoporotic Refracture". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05866029. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*